Markets:

Overview

News

Currencies

International

Treasuries

Cognition Therapeutics, Inc. - Common Stock (NQ:CGTX)

0.9129 +0.0083 (+0.92%)

Streaming Delayed Price Updated: 10:12 AM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cognition Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 04, 2023

Via Benzinga

Cognition Therapeutics Releases New Episode of “Conversations” Podcast Recorded at CTAD with Quantitative EEG Experts, Drs Willem de Haan and Philip Scheltens

November 16, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

Cognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer’s and Parkinson’s Diseases

November 15, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

Cognition Therapeutics's Earnings Outlook ↗

August 07, 2023

Via Benzinga

Cognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease

November 07, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

November 02, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 27, 2023

Gainers NKGen Biotech, Inc. (NASDAQ: NKGN) shares surged 60.9% to $6.08 in pre-market trading after gaining 8% on Thursday. NKGen Biotech presented Phase I clinical trial data at the 16th Annual...

Via Benzinga

Cognition Therapeutics and Collaborators at Yale and ACTC Announce Oral Late-breaking Presentation on the START Study in Early Alzheimer’s Disease at CTAD

October 27, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 26, 2023

Via Benzinga

Why Endeavor Group Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket ↗

October 26, 2023

Gainers Appreciate Holdings, Inc. (NASDAQ: SFR) shares surged 103.8% to $0.2460 in pre-market trading after falling around 19% on Wednesday. Appreciate Holdings received a notice from Nasdaq regarding...

Via Benzinga

Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 26, 2023

Gainers

Via Benzinga

Why Microsoft Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

October 25, 2023

Gainers ReShape Lifesciences Inc. (NASDAQ: RSLS) shares surged 62.8% to $0.3348 in pre-market trading after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million...

Via Benzinga

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 25, 2023

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 24, 2023

Via Benzinga

Cognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at CTAD

October 24, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 16, 2023

Via Benzinga

Cognition Therapeutics Presents New Data at CTAD Conference from Advancing Pipeline Across Multiple CNS Indications

October 16, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

Cognition Therapeutics Announces New Conversations Episode on Therapeutic Strategies to Protect the Retina in Dry AMD

September 07, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

Cognition Therapeutics Announces Participation in Upcoming September Conferences

August 30, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update

August 08, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

Cognition Therapeutics to Report Second Quarter 2023 Results in Conference Call on Tuesday, August 8, 2023

August 02, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

Cognition Therapeutics Announces Dosing of First Patient in MAGNIFY Study of Oral CT1812 for Geographic Atrophy Secondary to Dry AMD

July 11, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

Cognition Therapeutics – Could This Company's Technology Make Debilitating Neural Diseases Like Dementia A Thing Of The Past? ↗

July 06, 2023

Cognition Therapeutics, Inc. (NASDAQ: CGTX) is a clinical stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic...

Via Benzinga

Cognition Therapeutics and the Alzheimer's Clinical Trials Consortium Initiate First Clinical Site in the Phase 2 START Study in Early Alzheimer’s Disease

July 05, 2023

From Cognition Therapeutics, Inc.

Via GlobeNewswire

Crude Oil Rises Sharply; Unifirst Earnings Miss Expectations ↗

June 28, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 100 points on Wednesday. The Dow traded down 0.32% to 33,818.48 while the NASDAQ rose 0.23% to 13,586.93. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 28, 2023

Via Benzinga

Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 28, 2023

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.

Via Benzinga

Nasdaq Moves Higher; US Crude Stocks Drop More than Projected ↗

June 28, 2023

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 80 points on Wednesday. The Dow traded down 0.42% to 33,784.59 while the NASDAQ rose 0.63% to 13,640.83. The S&P...

Via Benzinga

Why Cognition Therapeutics Stock Is Plunging On Alzheimer's Disease Related News Today ↗

June 28, 2023

Cognition Therapeutics Inc (NASDAQ: CGTX) announced the topline results from its Phase 2 double-blind, single-crossover SEQUEL study of CT1812 in 16 adults with mild-to-moderate Alzheimer's disease.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.